Skip to main content
WoMWeb of Medicine
SearchGraphHistory
Family Medicine›Condition·Updated Jul 11, 2026·v1

Value-Based Care Models

Value-based care models shift reimbursement from volume to value, using ACOs, bundled payments, capitation, and pay-for-performance to align incentives with quality and cost. Evidence shows modest cost savings (1-2% per episode) and maintained quality, but challenges include risk adjustment disparities, comorbidity documentation mismatch, and vulnerability to external shocks like COVID-19. Optimizing modifiable factors (TXA use, multimodal analgesia) and implementing integrated care pathways can improve outcomes under VBC.

Moderate Evidence49 references·7,832 words·32 min read·v1
value-based carealternative payment modelsaccountable care organizationsbundled paymentcapitationquality measurementrisk adjustmentpopulation healthfamily medicinehealthcare delivery

Quick Reference

RxDrug of choiceRisk-adjusted capitation or bundled payment with quality performance incentives.
AltAlternativesFee-for-service (not recommended); pay-for-performance as a transitional model.
⊘AvoidPure capitation without risk adjustment; fee-for-service for complex populations.
DxTest of choiceComposite dashboard: quality metrics + total cost of care + patient-reported outcomes over 12 months with risk adjustment.
ScKey scoreCharlson Comorbidity Index; Proportion of Days Covered (PDC); KOOS/PASS.
→When to referPatient with poor PROMs or repeated readmissions >6 months post-surgery; refer to quality improvement team or specialty medical home.
Value-based care models reduce costs without harming quality when properly risk-adjusted, but require ongoing measurement and reconciliation to avoid penalizing complex patients.
Value-based care (VBC) models restructure healthcare reimbursement from volume-driven fee-for-service to systems that reward quality, outcomes, and cost efficiency. Key models include accountable care organizations (ACOs), bundled payments, capitation, patient-centered medical homes, and pay-for-performance. Evidence demonstrates that VBC can reduce spending by 1-2% per episode without harming quality, but success depends on robust risk adjustment, accurate quality measurement, and care coordination. Challenges include comorbidity documentation mismatches, vulnerability to external disruptions, and potential access penalties for complex populations. Optimizing modifiable perioperative factors and integrating technology-enabled chronic disease management are actionable strategies to improve VBC performance.

Overview and Recommendations

Background

  • •Value-based care (VBC) models represent a fundamental shift from volume-based to payment systems that reward quality, outcomes, and cost efficiency, a transformation driven by the recognition that the US healthcare system spends more per capita than any other developed nation yet achieves inferior outcomes on several measures.
  • •The main VBC models include s (ACOs), s, , s, and , each with a distinct payment mechanism and level of provider risk, ACOs use shared savings with a target budget, while capitation transfers full financial risk to the provider for a defined population.
  • •The defining feature of all VBC models is that provider financial risk is proportional to accountability for patient outcomes; the more risk assumed, the greater the potential reward (and penalty) for quality and cost performance.
  • •The push toward VBC accelerated after the Affordable Care Act (2010), with the Medicare Shared Savings Program (MSSP, 2012) and Bundled Payments for Care Improvement (BPCI) demonstrating that aligning incentives with quality metrics can reduce costs by 1-2% per episode without harming outcomes.
  • •Early experiments with pure capitation in the 1990s were largely abandoned because they encouraged underuse of necessary services and destabilized safety-net providers, a cautionary lesson that risk adjustment and quality measurement are essential companions to payment reform.
  • •The modern standard emphasizes holistic, patient-centric models that address medical, behavioral, and social needs, integrating digital tools for self-management and patient-reported outcome tracking, seen in the '360 IBD Care' model and post-acute certification programs.

Evaluation

  • •Suspect poor VBC model performance when quality measures decline, during the COVID-19 pandemic, federally qualified health centers saw cervical cancer screening drop 3.8 percentage points, depression screening drop 7.0 points, and blood pressure control drop 6.5 points, with most not recovering by 2021.
  • •Measure total cost of care using per patient per month (PMPM) or episode-based costing, for instance, commercially insured patients with metastatic pancreatic cancer incur costs 186% higher than Medicare patients ($95,426-$116,325 vs $39,777-$40,390), highlighting opportunities for cost standardization.
  • •Use (TDABC) to detect variability in resource use and identify modifiable cost drivers, in spine surgery, costs range from $201.78 for a multidisciplinary conference to $30,566 for a 2-level anterior cervical discectomy and fusion.
  • •Track patient-reported outcome measures (PROMs) like the Knee Injury and Osteoarthritis Outcome Score (KOOS) and SF-12 for joint arthroplasty; target achievement of the minimal clinically important difference (MCID) and patient acceptable symptom state (PASS) as key VBC quality thresholds.
  • •Assess modifiable perioperative factors that affect PROMs: use increases odds of KOOS MCID (OR 1.33) and PASS (OR 1.29); thromboprophylaxis reduces those odds (OR 0.68 and 0.73); in-hospital opioid use independently predicts failure to achieve SF-12 mental component improvement (OR 0.56).
  • •Examine risk stratification accuracy by reconciling payer-reported comorbidities with institutional records, kappa values range from 0.062 to 0.791 for THA/TKA conditions, with diabetes the only condition showing strong agreement; poor agreement places institutions at disadvantage in risk-adjusted contracts.
  • •Benchmark adherence measures like proportion of days covered (PDC) for statins, targeting ≥0.80, a pharmacy student outreach program increased mean PDC from 0.66 to 0.79, converting 35% of nonadherent patients to adherence.
  • •Identify low-value care: after primary THA with normal preoperative hemoglobin and TXA use, routine postoperative CBCs provided no actionable information and should be eliminated.
  • •Evaluate referral thresholds: pulmonary rehabilitation after COPD hospitalization is underutilized; specialty medical homes for IBD and Kidney Care Choices for CKD can improve outcomes but require appropriate patient selection.
  • •Use composite dashboards integrating quality, cost, and patient experience with mandatory risk adjustment to fairly compare VBC model performance across populations.

Management

  • •Define the attributed patient population or episode, collect baseline data on quality measures, total cost, and PROMs, then risk-adjust for demographics, comorbidities, and social determinants before benchmarking against national targets.
  • •Optimize modifiable perioperative factors in joint arthroplasty: administer in TKA to improve KOOS MCID and PASS achievement; avoid thromboprophylaxis as it reduces odds of meeting these quality thresholds, alternative VTE prophylaxis may be preferred.
  • •Minimize length of stay (LOS) through enhanced recovery protocols, each additional day increases in-hospital complications (OR 1.50) and 90-day readmissions (OR 1.23), but also increases odds of home discharge (OR 2.5), creating a tension that requires balanced pathway design.
  • •Use multimodal analgesia and limit in-hospital opioid use to preserve mental health outcomes, opioid use independently predicts failure to achieve SF-12 mental component MCID (OR 0.56).
  • •For acute decompensation in chronic conditions, match patient acuity to the lowest-cost effective setting using validated risk scores (e.g., Hospital Frailty Risk Score), avoid unnecessary hospitalizations when safe outpatient management is possible.
  • •In advanced CKD (stages 4-5), consider a very low protein diet (0.3 g/kg/day) supplemented with to delay dialysis initiation, monitor for malnutrition over 2-week assessment period.
  • •Implement post-acute care certification programs (e.g., AHA/ASA post-acute certification) to standardize transitions from hospital to skilled nursing facility, reducing readmission rates through consistent geriatric assessments and guideline-directed therapies.
  • •Integrate technology-enabled diabetes self-management education and support (DSMES) that includes bidirectional communication, use of patient-generated health data, tailored education, and individualized feedback, 18 of 25 reviews show significant A1c reduction.
  • •Refer for definitive surgical interventions when cost-effective: total hip arthroplasty reduces annual claims costs by ≥$250 per patient compared to nonoperative management across all payer types.
  • •Refer to pulmonary rehabilitation after COPD hospitalization, use validated decision rules to identify eligible patients, as this intervention reduces readmissions and costs but remains underutilized.
  • •Avoid routine postoperative labs after THA in patients with normal preoperative hemoglobin who received TXA, no actionable information results from such testing.
  • •Ensure risk adjustment includes octogenarian status and dual-eligibility as covariates to avoid penalizing hospitals serving complex populations, octogenarians have 21% readmission rate vs 12% in younger patients.
  • •Collaborate with payers to reconcile comorbidity records using standardized coding to ensure fair risk-adjusted payments, identify discrepancies in conditions like hypertension and obesity.
  • •For robotic-assisted total joint arthroplasty, consider leasing models to manage upfront costs; value is institution-dependent and requires procedural clustering and experienced teams to see benefits.
  • •Implement measurement-based care for depression using repeated validated symptom measures, this aligns with VBC by improving outcomes and tracking response.
  • •Screen for social determinants of health (food insecurity, housing, transportation) and connect patients to community resources to address the root causes of poor outcomes.
  • •Use registry-based recall and telehealth integration to maintain preventive screening and immunization rates, which are vulnerable to disruptions as seen during the COVID-19 pandemic.

Board Review — High Yield

  • •Accountable Care Organization (ACO) - Providers share savings when spending below budget while meeting quality benchmarks.
  • •Bundled payment - Single fixed payment for an episode of care; incentivizes care coordination across all providers.
  • •TDABC - Time-driven activity-based costing detects variability in resource use and identifies modifiable cost drivers.
  • •Tranexamic acid - Use in TKA increases odds of achieving KOOS MCID (OR 1.33) and PASS (OR 1.29).
  • •Aspirin thromboprophylaxis - Reduces odds of achieving KOOS MCID and PASS in TKA.
  • •Octogenarians - Higher comorbidity, readmission (21% vs 12%), and mortality under VBC; risk adjustment needed.
  • •Comorbidity documentation mismatch - Poor kappa (0.062-0.791) between payer and institutional records; diabetes only strong agreement.
  • •Pure capitation - Abandoned due to underuse and safety-net destabilization.
  • •Post-acute certification - AHA/ASA proposal to standardize care transitions and reduce readmissions.
  • •Measurement-based care - Repeated validated symptom measures improve depression outcomes in VBC.

Deep Dive — Evidence Details

References

  1. [1]

    Zhang D, Dyer GSM, Earp BE et al.. “Ten-year National Trends in Patient Characteristics and 30-day Outcomes of Distal Radius Fracture Open Reduction and Internal Fixation.” Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (2022). PMID: 36137213 ↗

    L2OTHERCited in: Definition, Classification and Nomenclature, Complications
  2. [2]

    Tomicki S, Dieguez G, Latimer H et al.. “Real-World Cost of Care for Commercially Insured versus Medicare Patients with Metastatic Pancreatic Cancer Who Received Guideline-Recommended Therapies.” American health & drug benefits (2021). PMID: 34267862 ↗

    L2OTHERCited in: Definition, Classification and Nomenclature, Diagnosis and Workup
  3. [3]

    Louie PK, Younus I, Hanks T et al.. “The new era of cost analysis in spine surgery utilizing time-driven activity based costing: a systematic review and introduction of an enabling technology value index.” The spine journal : official journal of the North American Spine Society (2025). PMID: 40032167 ↗

    L2SR_OBSCited in: Pathophysiology and Mechanism
  4. [4]

    Isetts B. “Integrating Medication Therapy Management (MTM) Services Provided by Community Pharmacists into a Community-Based Accountable Care Organization (ACO).” Pharmacy (Basel, Switzerland) (2017). PMID: 29035338 ↗

    L4OTHERCited in: Pathophysiology and Mechanism
  5. [5]

    Sharma P, Shenoy A, Shroff H et al.. “Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities.” Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2024). PMID: 38471008 ↗

    L5REVIEW_NARRATIVECited in: Epidemiology, Etiology and Risk Factors, Long-term and Definitive Management, Prognosis and Natural History
  6. [6]

    Stauffer TP, Goltz DE, Wickman JR et al.. “Trends in outcomes following aseptic revision shoulder arthroplasty.” European journal of orthopaedic surgery & traumatology : orthopedie traumatologie (2023). PMID: 36964819 ↗

    L2OTHERCited in: Epidemiology, Etiology and Risk Factors, Long-term and Definitive Management, Prognosis and Natural History, Prevention, Screening and Health Maintenance
  7. [7]

    Sutton R, Lizcano J, Krueger CA et al.. “Evaluating Surgeon-influenced Factors for Total Knee Arthroplasty Value-based Reimbursement.” The Journal of the American Academy of Orthopaedic Surgeons (2025). PMID: 39879388 ↗

    L2OTHERCited in: Epidemiology, Etiology and Risk Factors, Clinical Presentation, Severity, Staging and Risk Stratification, History and Evolution of Treatment, Complications
  8. [8]

    Babroudi S, Weiner DE. “Acute Kidney Injury Care Following Hospitalization: Care Provision and Public Policy for Acute Kidney Injury Survivors.” Advances in kidney disease and health (2025). PMID: 40222808 ↗

    L5REVIEW_NARRATIVECited in: Epidemiology, Etiology and Risk Factors, Acute Management
  9. [9]

    Deane AE, Elmore JS, Mayes TL et al.. “Shifting From Best Practice to Standard Practice: Implementing Measurement-Based Care in Health Systems.” Child psychiatry and human development (2024). PMID: 38896285 ↗

    L5REVIEW_NARRATIVECited in: Epidemiology, Etiology and Risk Factors, Prevention, Screening and Health Maintenance
  10. [10]

    Daniels AH, Singh M, Nassar JE et al.. “Development of a Spine Surgery Center of Excellence: Rationale, Design, Implementation, and Assessment of Outcomes.” The Journal of bone and joint surgery. American volume (2025). PMID: 40763208 ↗

    L5REVIEW_NARRATIVECited in: Epidemiology, Etiology and Risk Factors, Complications
  11. [11]

    Cole MB, Lee EK, Frogner BK et al.. “Changes in Performance Measures and Service Volume at US Federally Qualified Health Centers During the COVID-19 Pandemic.” JAMA health forum (2023). PMID: 37027165 ↗

    L2OTHERCited in: Epidemiology, Etiology and Risk Factors, Diagnosis and Workup, Prevention, Screening and Health Maintenance
  12. [12]

    Gandjian M, Williamson C, Sanaiha Y et al.. “Continued Relevance of Minimum Volume Standards for Elective Esophagectomy: A National Perspective.” The Annals of thoracic surgery (2021). PMID: 34437854 ↗

    L2OTHERCited in: Epidemiology, Etiology and Risk Factors, Complications
  13. [13]

    Forman DE, Carey RM, Block S et al.. “Post-acute cardiovascular and stroke care and the potential of certification programs: A 'Call to Action'.” The American journal of medicine (2026). PMID: 41616928 ↗

    L5REVIEW_NARRATIVECited in: Clinical Presentation, Acute Management, History and Evolution of Treatment, Prevention, Screening and Health Maintenance
  14. [14]

    Kildow BJ, Howell EP, Karas V et al.. “When Should Complete Blood Count Tests Be Performed in Primary Total Hip Arthroplasty Patients?” The Journal of arthroplasty (2018). PMID: 29908797 ↗

    L2OTHERCited in: Diagnosis and Workup
  15. [15]

    Tamargo C, Sando K, Prados Y et al.. “Change in Proportion of Days Covered for Statins Following Implementation of a Pharmacy Student Adherence Outreach Program.” Journal of managed care & specialty pharmacy (2019). PMID: 31039060 ↗

    L4OTHERCited in: Diagnosis and Workup
  16. [16]

    Gross MD, Alshak MN, Shoag JE et al.. “Healthcare Costs of Post-Prostate Biopsy Sepsis.” Urology (2019). PMID: 31229516 ↗

    L5REVIEW_NARRATIVECited in: Diagnosis and Workup
  17. [17]

    Farquhar DR, Lenze NR, Tasoulas J et al.. “Comparison of surgical margins and adjuvant therapy for head and neck cancer by hospital type.” Translational cancer research (2024). PMID: 39430853 ↗

    L2OTHERCited in: Diagnosis and Workup
  18. [18]

    Usman M, Seidman J, Rice K. “Development of an economic model to quantify the impact of clubhouses on societal costs.” Psychiatric rehabilitation journal (2025). PMID: 41182724 ↗

    L5OTHERCited in: Diagnosis and Workup
  19. [19]

    Sarikonda A, Sami A, Self DM et al.. “Are Mildly Disabled Patients Appropriate for Spine Bundles? An Application of the Operative Value Index.” World neurosurgery (2025). PMID: 39983987 ↗

    L2OTHERCited in: Diagnosis and Workup
  20. [20]

    Meador M, Sachdev N, Anderson E et al.. “Self-Measured Blood Pressure Monitoring During the COVID-19 Pandemic: Perspectives From Community Health Center Clinicians.” Journal for healthcare quality : official publication of the National Association for Healthcare Quality (2023). PMID: 38150376 ↗

    L5OTHERCited in: Diagnosis and Workup
  21. [21]

    Hobbs JR, Magnuson JA, Woelber E et al.. “Comparing Risk Assessment Between Payers and Providers: Inconsistent Agreement in Medical Comorbidity Records for Patients Undergoing Total Joint Arthroplasty.” The Journal of arthroplasty (2023). PMID: 37179022 ↗

    L2OTHERCited in: Severity, Staging and Risk Stratification, Complications
  22. [22]

    Malkani AL, Dilworth B, Ong K et al.. “High Risk of Readmission in Octogenarians Undergoing Primary Hip Arthroplasty.” Clinical orthopaedics and related research (2017). PMID: 28083755 ↗

    L2OTHERCited in: Severity, Staging and Risk Stratification, Complications, Special Populations and Pregnancy
  23. [23]

    Emamekhoo H, Riaz IB, Martin DB et al.. “Deriving wisdom from data: The value and continued rationale for structured data in the era of artificial intelligence-driven oncology care.” Cancer (2026). PMID: 41701629 ↗

    L5REVIEW_NARRATIVECited in: Severity, Staging and Risk Stratification
  24. [24]

    Raman SV, Smolensky AV, Ramchandani J et al.. “Health Plan-Based Atherosclerosis Imaging for Members with Diabetics: Utilization and Impact on Subsequent Episodes of Care.” JACC. Advances (2026). PMID: 41570795 ↗

    L2OTHERCited in: Severity, Staging and Risk Stratification
  25. [25]

    Saville J, Moore LW, Narasaki Y et al.. “Kidney Nutrition for Value-Based Care Models: The Role of Low Protein Diets and Keto-Analogue Supplementation to Delay Dialysis.” Clinical journal of the American Society of Nephrology : CJASN (2025). PMID: 40932799 ↗

    L5OTHERCited in: Acute Management, Long-term and Definitive Management
  26. [26]

    Stone AB, Dasani SS, Grant MC et al.. “Understanding the Economic Impact of an Essential Service: Applying Time-Driven Activity-Based Costing to the Hospital Airway Response Team.” Anesthesia and analgesia (2022). PMID: 35180159 ↗

    L4OTHERCited in: Acute Management
  27. [27]

    Gettel CJ, Tinloy B, Nedza SM et al.. “The future of value-based emergency care: Development of an emergency medicine MIPS value pathway framework.” Journal of the American College of Emergency Physicians open (2022). PMID: 35310403 ↗

    L5OTHERCited in: Acute Management
  28. [28]

    Abe EA, Parikh N, Nemirov DA et al.. “Health Care Utilization and Costs in the Year Before and After Total Hip Arthroplasty.” The Journal of arthroplasty (2025). PMID: 40602451 ↗

    L3OTHERCited in: Acute Management, Long-term and Definitive Management
  29. [29]

    Samuel LT, Karnuta JM, Banerjee A et al.. “Robotic Arm-Assisted versus Manual Total Knee Arthroplasty: A Propensity Score-Matched Analysis.” The journal of knee surgery (2021). PMID: 34187067 ↗

    L2OTHERCited in: Acute Management, Complications
  30. [30]

    Rodriguez K, Valan B, Holleran S et al.. “Racial Disparities in Total Joint Arthroplasty Bundled Payment Data.” Arthroplasty today (2025). PMID: 40510196 ↗

    L3OTHERCited in: Acute Management
  31. [31]

    Macy ML, Kim CS, Sasson C et al.. “Pediatric observation units in the United States: a systematic review.” Journal of hospital medicine (2010). PMID: 20235288 ↗

    L2SR_OBSCited in: Long-term and Definitive Management, Prognosis and Natural History
  32. [32]

    Greenwood DA, Gee PM, Fatkin KJ et al.. “A Systematic Review of Reviews Evaluating Technology-Enabled Diabetes Self-Management Education and Support.” Journal of diabetes science and technology (2017). PMID: 28560898 ↗

    L2SR_OBSCited in: Long-term and Definitive Management, Prognosis and Natural History
  33. [33]

    Chen Z, Gudi M, Lindahl A et al.. “Calculating Value in Hand and Wrist Care: A Systematic Review on the Current Literature.” Journal of hand surgery global online (2025). PMID: 41624319 ↗

    L2SR_OBSCited in: Long-term and Definitive Management
  34. [34]

    Jain G, Weiner DE. “Value-Based Care in Nephrology: The Kidney Care Choices Model and Other Reforms.” Kidney360 (2021). PMID: 35372980 ↗

    L5REVIEW_NARRATIVECited in: Long-term and Definitive Management
  35. [35]

    Magruder ML, Delanois RE, Scuderi GR et al.. “Relative-Value Units in Arthroplasty: Past, Present, and Future.” The Journal of arthroplasty (2024). PMID: 39579803 ↗

    L5REVIEW_NARRATIVECited in: Long-term and Definitive Management
  36. [36]

    Click B, Regueiro M. “The Inflammatory Bowel Disease Medical Home: From Patients to Populations.” Inflammatory bowel diseases (2019). PMID: 30934057 ↗

    L5REVIEW_NARRATIVECited in: Long-term and Definitive Management
  37. [37]

    Jevnikar BE, Khan ST, Emara AK et al.. “Robotic total hip and knee arthroplasty: economic impact and workflow efficiency.” Journal of robotic surgery (2025). PMID: 40921892 ↗

    L5REVIEW_NARRATIVECited in: Long-term and Definitive Management, Complications, Prognosis and Natural History
  38. [38]

    Osoro L, Zylla MM, Braunschweig F et al.. “Challenging the status quo: a scoping review of value-based care models in cardiology and electrophysiology.” Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2024). PMID: 39158601 ↗

    L2REVIEW_NARRATIVECited in: Long-term and Definitive Management
  39. [39]

    Click B, Cross RK, Regueiro M et al.. “The IBD Clinic of Tomorrow: Holistic, Patient-Centric, and Value-based Care.” Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association (2024). PMID: 39025251 ↗

    L5REVIEW_NARRATIVECited in: History and Evolution of Treatment
  40. [40]

    Peyrottes A, Dariane C, Brureau L et al.. “Digital Systematic Collection of Data for Patient-reported Outcome and Experience Measures Reveals Real-world Recovery Trajectories After Robot-assisted Radical Prostatectomy.” European urology focus (2025). PMID: 41421930 ↗

    L3OTHERCited in: History and Evolution of Treatment
  41. [41]

    Garvey C. “Pulmonary Rehabilitation Reimbursement Challenges.” Respiratory care (2024). PMID: 38688548 ↗

    L5REVIEW_NARRATIVECited in: Generalist Reasoning under Diagnostic Uncertainty, Point-of-Care Scores & Referral Thresholds
  42. [42]

    Shaikh S, Bafana R, Halabi SS. “Concierge and Second-Opinion Radiology: Review of Current Practices.” Current problems in diagnostic radiology (2015). PMID: 26305521 ↗

    L5REVIEW_NARRATIVECited in: Generalist Reasoning under Diagnostic Uncertainty, Point-of-Care Scores & Referral Thresholds
  43. [43]

    Malay MR, Lentz TA, O'Donnell J et al.. “Development of a Comprehensive, Nonsurgical Joint Health Program for People With Osteoarthritis: A Case Report.” Physical therapy (2020). PMID: 31596479 ↗

    L4CASE_REPORTCited in: Generalist Reasoning under Diagnostic Uncertainty, Point-of-Care Scores & Referral Thresholds
  44. [44]

    Kolin DA, Moverman MA, Pagani NR et al.. “Substantial Inconsistency and Variability Exists Among Minimum Clinically Important Differences for Shoulder Arthroplasty Outcomes: A Systematic Review.” Clinical orthopaedics and related research (2022). PMID: 35302970 ↗

    L2SR_OBSCited in: Prognosis and Natural History
  45. [45]

    Quraishi D, Sarikonda A, Mitchell Self D et al.. “Experience Matters: An Application of the Operative Value Index for Lumbar Fusions.” Neurosurgical review (2025). PMID: 40694162 ↗

    L3OTHERCited in: Prognosis and Natural History
  46. [46]

    DeVito RG, Ke BG, Park RH et al.. “The Financial Impact of a Cosurgeon in Breast Microsurgery.” Plastic and reconstructive surgery (2024). PMID: 39356712 ↗

    L3OTHERCited in: Prognosis and Natural History
  47. [47]

    Freed SS, Frascino N, Jones KA et al.. “Opportunities for Integration in the Dual Medicare-Medicaid Population: North Carolina Landscape Analysis.” North Carolina medical journal (2024). PMID: 39412325 ↗

    L5OTHERCited in: Special Populations and Pregnancy
  48. [48]

    Kefalas CH, Kaminski MA. “The Role of Social Determinants of Health in Gastroenterology Care.” Population health management (2025). PMID: 40919660 ↗

    L4OTHERCited in: Prevention, Screening and Health Maintenance
  49. [49]

    Song J, Wu KA, Mai E et al.. “Factors associated with conversion of outpatient total shoulder arthroplasty to inpatient.” Journal of shoulder and elbow surgery (2026). PMID: 42069131 ↗

    L3OTHERCited in: Prevention, Screening and Health Maintenance

Revision History

All updates applied to this page

Loading revisions…